ST-01
Phase 2Small molecule
ST-01 is one of 70 small molecule programs targeting Post Operative Pain. It is currently in Phase 2.
2
Indications
2
Total Trials
2
Active Trials
69
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
64 competitors in Post Operative Pain
#DrugCompanyPhaseTrials
1Marcaine
IInnocoll
Approved
Advil
KKenvue Brands
Approved
Duragesic
CCephalon
Approved
Journavx
Vertex PharmaceuticalsApproved
Tylenol
KKenvue Brands
Approved
Ketalar
AAultman Health Foundation
Approved
Epsom Salt
FFresenius Kabi USA, LLC
Approved
Achromycin V
WWyeth-Lederle Vaccines
Approved
Cyklokapron
JJ Molner
Phase 3
Bupivacain
IIstanbul University
Phase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for ST-01. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 2[1]
- Company
- SSustained Therapeutics Inc.